Wealth Enhancement Advisory Services’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$39.6K Buy
2025
Q1
$23.6K Buy